Clinical trial
The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY
NCT06823596
Study timeline
Study start (actual)2025-01-14Date precision: day
Registry last updated2026-03-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hivunresolved
Interventions
Efavirenz 600mgDRUG
Sponsors & collaborators
University of Torontolead sponsor
Ontario HIV Treatment Networkcollaborator
Maple Leaf Researchcollaborator
Unity Health Torontocollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06823596 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.